Leadership team
The leadership team brings together clinical cerebrovascular expertise, vascular therapeutic development, and patient-centered translational research.
Programme Director
Professor Majid is Professor of Cerebrovascular Neurology at the University of Sheffield, with research spanning stroke trials, neuroprotection, and gene-targeted work for hereditary cerebral small-vessel diseases.
COL4A1 Therapeutics Lead
Dr Kocsy is an ARUK Research Fellow at the University of Sheffield. She leads the COL4A1 project space, bringing focus to disease biology, experimental strategy, and vascular therapeutic development.
CADASIL Therapeutics Lead
Dr Felix-Ilemhenbhio is a BHF Research Fellow at the University of Sheffield. He leads the CADASIL and NOTCH3 therapeutic testing space, translating gene therapy concepts into experimental systems with a clear patient-centered vision.
